QART Medical is excited to announce that its cofounder, Professor Natan Shaked, was recently featured in an article in Medialine. The piece highlights Professor Shaked’s groundbreaking work in advancing IVF technology, with a focus on QART Medical’s innovative use of quantitative phase microscopy to analyze sperm cells in a clinical setting.
To read the article on the Medialine website please Click Here.
Professor Natan Shaked, cofounder of QART Medical
QART Medical is an ISO13485 certified MedTech company addressing the global infertility epidemic. To do so, QART has developed the Q300™, a breakthrough solution to male infertility issues that provides a quantitative characterization of sperm cell morphology to facilitate informed clinical decision making when selecting cells for use in in-vitro fertilization (IVF). QART aims to improve current success rates of Intra-Cytoplasmic Sperm Injection (ICSI) by quantitatively characterizing the morphology and composition of individual sperm cells with 3D imaging. The Q300™ is registered with the US FDA, has received Israeli regulatory registration for commercial sales, and bears the CE (Conformité Européenne) Mark.